Express Delivery
All orders are shipped with Econt
Cash on delivery
Reliable and convenient payment methods
Proven quality
Peptides Tested at Janoshik Labs
Express delivery in 1-3 business days.
Each peptide comes with bacteriostatic water.
Thymosin beta-4 is a natural peptide, composed of 43 amino acids, present in almost all human and animal tissues.
It belongs to the family of thymosin peptides and has been described in research models with a role in cell migration, angiogenesis, inflammatory response, and restorative processes. The synthetic version of this peptide is more widely known as TB-500. Thymosin Beta-4 is particularly active in areas of tissue damage, where it stimulates cell regeneration and the formation of new blood vessels.
These properties are why Thymosin Beta-4 is a subject of research interest in orthopedics, cardiology, dermatology, and sports medicine.
Thymosin Beta-4 is being researched for its possible effects on:
Healing of muscle and tendon injuries – an effect on recovery processes and tissue regeneration has been observed in research models.
Stimulation of angiogenesis – a described effect on the formation of new capillaries and local blood supply.
Anti-inflammatory effect – observed influence on inflammatory mediators and local edema.
Joint and bone health – a described effect on recovery processes after joint and bone injuries.
Healing of skin and connective tissue lesions – an effect on the healing of wounds and surgical incisions has been observed in research settings.
Improved recovery in athletes – faster recovery after exertion has been described in experimental models.
Neuroprotective potential – an observed role in peripheral nerve regeneration and limitation of neurotoxic damage.
In scientific literature, subcutaneous administration of doses from 0.5mg to 2mg, applied 3 times a week for 4-6 weeks, is most commonly encountered.
For 5 mg + 3 ml bacteriostatic water: 1.67 mg/ml → 0.15 ml = 0.25 mg = 250µg
Example values for 5 mg:
0.15 ml = 250µg
0.3 ml = 500µg
0.45 ml = 750µg
0.6 ml = 1 mg
0.75 ml = 1.25 mg
Thymosin Beta-4 has been extensively studied in preclinical settings and in limited clinical trials.
In orthopedic research models, effects on tendon and muscle injury recovery, as well as on osteogenesis and inflammatory processes in joints, have been described.
In cardiological research models, a protective effect in ischemic myocardial damage has been observed, linked to angiogenesis and improved local blood supply.
In dermatological and plastic surgery studies, an effect on the healing of chronic skin wounds, ulcers, and surgical scars has been described.
In neurological research models, a potential effect on nerve cell protection and axon regeneration has been observed.
Thymosin Beta-4 is prohibited by WADA for use in professional sports because it can:
accelerate recovery after muscle and tendon injuries
improve blood supply and tissue healing
reduce recovery time between heavy loads
increase endurance through optimized local circulation
Rare and mild reactions have been described in research conditions, such as:
fatigue
headache
dizziness
redness or pain at the injection site
Less commonly, changes in appetite, drowsiness, or slight fluid retention may be observed.
The information is gathered and systematized from various scientific sources and studies. It serves solely for educational purposes and should not be used for the diagnosis, treatment, or prevention of diseases.